Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed attachment file name title grouped question UIN question first answered answering member label previous answer version answering member constituency answering member printed answering member
tabling member	label

Search

1190814

	registered interest
	date	27/04/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Coronavirus: Death
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, by what date he plans to publish on a daily basis non-hospital deaths with covid-19.
	tabling member constituency	Sheffield South East
	tabling member printed	Mr Clive Betts
	uin	40507
	answer	answer is ministerial correction date of answer 12/05/2020 answer text <p>From 29 April, figures for deaths include all cases where there is a positive confirmed test for COVID-19. The figures include deaths with laboratory-confirmed COVID-19 in all settings, not just those in hospital, and this provides us with a single figure on an equivalent basis for the whole of the United Kingdom.</p><p>These UK figures are compiled from validated data provided by each of the four nations of the UK. Figures from Health Protection Scotland, Public Health Wales and the Public Health Agency (Northern Ireland) have always included tested cases outside hospital. Figures for England from 29 April onwards are provided by Public Health England and draw together several different data sources, including data from NHS England and NHS Improvement, to produce this broader measure.</p><p>This approach allows us to compile deaths data on a daily basis using up-to-date figures across all settings.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 12/05/2020 10:10:55 answering member 4380 label Biography information for Jo Churchill previous answer version 18670 answering member constituency Mid Bedfordshire answering member printed Ms Nadine Dorries answering member 1481
	tabling member	394 label Biography information for Mr Clive Betts

1045911

	registered interest
	date	22/01/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Continuing Care
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many people received continuing health care in each Care Commission Group; and the cost of that care in each of the last five years.
	tabling member constituency	Sheffield South East
	tabling member printed	Mr Clive Betts
	uin	211100
	answer	answer is ministerial correction date of answer 28/01/2019 answer text <p>A table showing the number of cases found eligible for NHS Continuing Healthcare (CHC) during the years from 2013-14 to 2017-18 is attached. The table refers to the clinical commissioning groups (CCGs) at that time; the total is for both standard and fast track NHS CHC.</p><p> </p><p>Tables showing CCG total NHS CHC expenditure by year, 2013-14 to 2017-18 is attached. Due to different number of weeks paid for in a care package, it is not possible to calculate an average package cost. Activity and cost data cannot therefore be used to approximate cost per person.</p> answering member constituency Gosport answering member printed Caroline Dinenage attachment 1 file name PQ211100 Annex B cost of CHC by CCG.xlsx title PQ211100 attached table 2 file name PQ211100 Annex A Number eligible by CCG format.xlsx title PQ211100 attached table question first answered 28/01/2019 14:37:07 answering member 4008 label Biography information for Dame Caroline Dinenage
	tabling member	394 label Biography information for Mr Clive Betts

1082575

	registered interest
	date	06/03/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Respite Care
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how much funding allocated to councils for respite care has been accessed to date; and what steps his Department is taking to encourage carers to make use of that support.
	tabling member constituency	Sheffield South East
	tabling member printed	Mr Clive Betts
	uin	229090
	answer	answer is ministerial correction date of answer 11/03/2019 answer text <p>Since 2015, the National Health Service contribution to the Better Care Fund (BCF) has included funding to support the implementation of the Care Act 2014, including £130 million which has been made available each year for Carers’ Breaks via the NHS clinical commissioning groups (CCG) minimum contribution to the BCF.</p><p>Locally agreed between local authorities (LAs) and CCGs, joint BCF plans set out the level of resource that will be dedicated to carer-specific support, including carers’ breaks, and identify how the chosen methods for supporting carers will help to meet key outcomes. These BCF plans are agreed locally at Health and Wellbeing Board level as part of the BCF Assurance process, and funding is released under the premise that the requirements and conditions of the Fund are met. The local level allocation data is not readily available at a national level.</p><p>We recognise the importance of carers being able to take a break from their caring role. Through the Carers Action Plan, we have committed to promoting best practice for LAs, service providers and commissioners on carer breaks and respite care. In doing so this will support them to help carers to take a break by highlighting best practice and provide advice and information for carers seeking respite breaks.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 11/03/2019 17:10:29 answering member 4008 label Biography information for Dame Caroline Dinenage
	tabling member	394 label Biography information for Mr Clive Betts

943001

	registered interest
	date	17/07/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Clinical Commissioning Groups: Disclosure of Information
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how much money his Department spent from the public purse on Care Commissioning Groups obtaining transparency orders in each of the last three years.
	tabling member constituency	Sheffield South East
	tabling member printed	Mr Clive Betts
	uin	164864
	answer	answer is ministerial correction date of answer 23/07/2018 answer text <p>Information on how much money clinical commissioning groups have spent on obtaining transparency orders is not collected centrally.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 23/07/2018 15:13:03 answering member 4067 label Biography information for Steve Brine
	tabling member	394 label Biography information for Mr Clive Betts

1175548

	registered interest
	date	03/02/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	National Institute for Health and Care Excellence
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how patient organisations were recruited to the 11 NICE methods review task and finish groups.
	tabling member constituency	Sheffield South East
	tabling member printed	Mr Clive Betts
	uin	11444
	answer	answer is ministerial correction date of answer 06/02/2020 answer text <p>The following patient groups are currently involved across the programme of task and finish groups. The National Institute for Health and Care Excellence (NICE) has advised that it continues to seek further members for the task and finish groups, and a full list of members is still to be finalised.</p><p>- Alzheimer's Research UK;</p><p>- Breast Cancer Now;</p><p>- Cancer52;</p><p>- Cystic Fibrosis Trust ;</p><p>- Diabetes UK;</p><p>- Genetic Alliance UK;</p><p>- Leukaemia CARE;</p><p>- Multiple Sclerosis Society;</p><p>- Muscular Dystrophy UK;</p><p>- Myeloma UK;</p><p>- Neuroendocrine Cancer UK;</p><p>- Prostate cancer UK; and</p><p>- Sarcoma UK.</p><p> </p><p>In recruiting patient organisations to the NICE methods review task and finish groups, patients on the methods working group were asked to nominate representatives with a range of experience. Additional representatives were nominated by NICE where particular expertise or input was required. The organisations involved in the task and finish groups cover a broad spectrum of disease areas including cancer, non-cancer and rare diseases.<strong> </strong></p> answering member constituency Bury St Edmunds answering member printed Jo Churchill grouped question UIN 11443 question first answered 06/02/2020 17:20:14 answering member 4380 label Biography information for Jo Churchill
	tabling member	394 label Biography information for Mr Clive Betts

1135184

	registered interest
	date	27/06/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Genomics: Screening
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how will new tests be added to the National Genomic Test Directory.
	tabling member constituency	Sheffield South East
	tabling member printed	Mr Clive Betts
	uin	270283
	answer	answer is ministerial correction date of answer 05/07/2019 answer text <p>During 2019, the National Health Service will begin to offer whole genome sequencing (WGS) as part of clinical care for:</p><p>- Seriously ill children likely to have a rare genetic disorder;</p><p>- People with one of 21 rare conditions where current evidence supports early adoption of WGS as a diagnostic test; and</p><p>- People with specific types of cancer for which there is likely to be the greatest patient benefit from using WGS – children with cancer, sarcoma and acute myeloid leukaemia.</p><p> </p><p>WGS will only replace existing diagnostic tests once the testing is demonstrated to be clinically safe to replace existing diagnostic testing. Initially, existing diagnostic testing will continue to be performed alongside WGS testing where clinically appropriate. This will continue until WGS is able to fully support clinical decision making within clinically appropriate timescales.</p><p>Current testing for blood cancers includes a number of diagnostic tests, the current expectation is that WGS will not be used to replace tests that require very fast turnaround times (under 24 hours) or high sensitivity.</p><p>WGS and non-WGS testing that will be available as part of clinical care is outlined in the National Genomic Test Directory at the following link:</p><p> </p><p><a href="https://www.england.nhs.uk/publication/national-genomic-test-directories/" target="_blank">https://www.england.nhs.uk/publication/national-genomic-test-directories/</a></p><p> </p><p>The UK Genetic Testing Network (UKGTN) published the NHS Directory of Genetic Disorders/Genes for Diagnostic Testing, which evaluated and recommended genetic tests for rare and inherited disorders for the National Health Service across the UK. However, there was not an equivalent for cancer genomic testing. The National Genomic Test Directory specifies which genomic tests are commissioned by the NHS in England, the technology by which they are available, and the patients who will be eligible to access to a test.</p><p>The National Genomic Test Directory will be updated on an annual basis and NHS England will implement a clear and transparent process, supported by a Clinical and Scientific Expert Panel, to determine which tests are available within the NHS. This will include reviewing any tests that may be retired or replaced by more modern technology, such as WGS. As the price of WGS falls and the clinical evidence improves, we envisage that it will be extended to more conditions and therefore more patients.</p><p> </p><p><strong> </strong></p><p><strong> </strong></p> answering member constituency Gosport answering member printed Caroline Dinenage grouped question UIN 270281 270282 question first answered 05/07/2019 09:24:02 answering member 4008 label Biography information for Dame Caroline Dinenage
	tabling member	394 label Biography information for Mr Clive Betts

1121970

	registered interest
	date	18/04/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Cancer: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 15 April 2019 to Question 242692 on Cancer: Drugs, what steps the Government is taking to give timely NICE and NHS approval to enable access to maintenance medication for people with cancer.
	tabling member constituency	Sheffield South East
	tabling member printed	Mr Clive Betts
	uin	245610
	answer	answer is ministerial correction date of answer 25/04/2019 answer text <p>Through its technology appraisal programme, the National Institute for Health and Care Excellence (NICE) makes recommendations for the National Health Service on whether drugs and other treatments represent an effective use of NHS resources. NHS England is legally required to fund cancer drugs recommended in NICE technology appraisal guidance.</p><p>The Government wants patients with cancer to be able to benefit from rapid access to effective new drugs, including for maintenance treatment. Under arrangements introduced in 2016, NICE now develops technology appraisal guidance for the NHS on all new cancer drugs. Wherever possible, NICE aims to issue draft guidance on new cancer drugs before licensing and to publish final guidance within 90 days of licensing.</p><p>Funding is available through the Cancer Drugs Fund from the point at which NICE draft recommendations are published, or if the drug is not currently licensed, from the point of licensing. This ensures patients are able to benefit from effective new cancer drugs as quickly as possible.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 25/04/2019 14:05:35 answering member 4455 label Biography information for Seema Kennedy
	tabling member	394 label Biography information for Mr Clive Betts

1124146

	registered interest
	date	01/05/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Cancer: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 25 April 2019 to Question 245610, how many forms of cancer have no maintenance drug available at any stage in the treatment plan.
	tabling member constituency	Sheffield South East
	tabling member printed	Mr Clive Betts
	uin	249828
	answer	answer is ministerial correction date of answer 08/05/2019 answer text <p>The information requested is not available.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 08/05/2019 13:54:02 answering member 4455 label Biography information for Seema Kennedy
	tabling member	394 label Biography information for Mr Clive Betts

1110552

	registered interest
	date	09/04/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Medical Treatments
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the adequacy of the appraisal process for personalised treatments for small patient groups.
	tabling member constituency	Sheffield South East
	tabling member printed	Mr Clive Betts
	uin	242693
	answer	answer is ministerial correction date of answer 15/04/2019 answer text <p>The National Institute for Health and Care Excellence (NICE) is the independent body that provides guidance on the prevention and treatment of ill health and the promotion of good health and social care. Through its technology appraisal and highly specialised technologies programmes, NICE plays an important role in ensuring that patients are able to benefit from effective new treatments, including treatments for small numbers of patients. NICE has recommended a number of drugs for small patient populations through these programmes that are now routinely funded by the National Health Service for eligible patients.</p><p> </p><p>NICE periodically reviews its methods and processes to ensure that they keep pace with developments in science and healthcare. NICE will be carrying out a review of its technology appraisal and highly specialised technologies methods in 2019/20.</p> answering member constituency South Ribble answering member printed Seema Kennedy question first answered 15/04/2019 12:55:57 answering member 4455 label Biography information for Seema Kennedy
	tabling member	394 label Biography information for Mr Clive Betts

819105

	registered interest
	date	09/01/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Department of Health and Social Care: Reorganisation
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what estimate he has made of the cost to the public purse of changing his Department's name.
	tabling member constituency	Sheffield South East
	tabling member printed	Mr Clive Betts
	uin	121782
	answer	answer is ministerial correction date of answer 17/01/2018 answer text <p>The costs of changing the name ‘Department of Health’ to ‘Department of Health and Social Care’ will be kept to an absolute minimum. The current estimate for costs associated to the name change will be no more than £1,000.</p><p> </p><p>Stationery, such as business cards and headed paper, will only be changed when stock is used up.</p><p> </p><p>Signage in the Department’s London headquarters is digital only. Physical signage in the Leeds headquarters will only be changed later in 2018, as part of a planned refurbishment of the building.</p><p> </p><p>Amends to the website and intranet have not incurred additional costs.</p> answering member constituency North East Cambridgeshire answering member printed Stephen Barclay question first answered 17/01/2018 14:11:56 answering member 4095 label Biography information for Steve Barclay
	tabling member	394 label Biography information for Mr Clive Betts